Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.
Also called NCT06780215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 116 participants
- Sponsor
- Yihan Chen
- Registry
-
NCT06780215
-
- Other papers using this trial's data
- Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06780215. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-17 (actual); primary completion 2025-09-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions
- Condition
- Premature Ventricular Contraction (PVC)
- Intervention (Drug)
- Varenicline Tartrate Tablets
- Intervention (Drug)
- Placebo
- Lead sponsor
- Yihan Chen
Record details
- Record id
cardio:ct-nct06780215- Content hash
6760ba96d1a153b5eacd70f6de5197e7d7d302c26dd1f0d7440db54a536a6982